Show simple item record

dc.contributor.authorDeSouza, R.D.
dc.contributor.authorBhandare, P.N.
dc.contributor.authorFernandes, N.
dc.contributor.authorWahidullah, S.
dc.contributor.authorDeSouza, L.
dc.date.accessioned2009-01-12T08:56:38Z
dc.date.available2009-01-12T08:56:38Z
dc.date.issued1997
dc.identifier.citationIndian Journal of Pharmacology, Vol.29; 327-328p.
dc.identifier.urihttp://drs.nio.org/drs/handle/2264/2013
dc.description.abstractIn the present study, compound (1) depressed both phases of the dose-response curve. The marked effect on 5-HT response cannot be attributed solely to an antimuscarinic action of the compound which was much less (66%) as compared to (88%) in the case of 5-HT. The varying inhibitory effect of the compound of different spasmogens acting via diverse mechanisms suggests that its locus of action may be at a post receptor site, at some step in the transduction pathway. Further work is needed to elucidate the exact mode of action of this compound
dc.language.isoen
dc.publisherIndian Pharmacological Society
dc.rightsCopyright [1997]. All efforts have been made to respect the copyright to the best of our knowledge. Inadvertent omissions, if brought to our notice, stand for correction and withdrawal of document from this repository.
dc.subjectbioactiv compounds
dc.subjectdrugs
dc.subjectscreening
dc.titleAntispasmodic action of 5-methyl benzoxazoline-2-one: A preliminary study
dc.typeJournal Article


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record